Physicians remain wary of the wellness trend ...

Roche Holding AG ( RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT ...

USD 11.58 billion; 2031 Projected Market Size: USD 16.39 billion; CAGR (2026–2031): 7.2%; Chemiluminescence Immun ...

In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first line of therapy did not improve overall survival (OS) ...

According to MarketsandMarkets, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion in 2026 to USD 16.39 ...

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral ...

Dr. Carolyn Mukai, ND, Dr. Lynn Klassen, ND, Dr. Ece Toprak, ND Expanding recognition of infection-triggered ...

A board games developer is set to become the first company to list its shares ‌on Britain's new private stock market later this month, in a ‌deal that will take place on a rival platform to that ...

Rising Wildfire Frequency Due to Climate Change, Increased Government Spending, and Technological Advancements in Aircraft Capabilities Drive Market Expansion.Austin, United States, March 10, 2026 ...

Endocrine reproductive disorders are disorders that affect the reproductive endocrine system and often result in fertility problems. Examples include ovarian insufficiency and polycystic ovary ...

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...